1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
   Jose Marin et al, 2022, Cancers CrossRef
2. Predictive Values of Blood-Based RNA Signatures for the Gemcitabine Response in Advanced Pancreatic Cancer
   David Piquemal et al, 2020, Cancers CrossRef
3. Epigenetic Changes and Potential Targets in Pancreatic Cancer
   Rajesh Singh et al, 2016, Epigenetic Advancements in Cancer CrossRef
4. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
   Daniel R. Principe et al, 2021, Frontiers in Oncology CrossRef
5. Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine
   Justine M. Grixti et al, 2017, Frontiers in Pharmacology CrossRef
6. Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression
   Ming-Chuan Hsu et al, 2018, Cancers CrossRef
7. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
   Belén Toledo et al, 2024, Expert Review of Clinical Pharmacology CrossRef
8. Aberrant DNA Methylation of ABC Transporters in Cancer
   Katja Zappe et al, 2020, Cells CrossRef
9. M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
   Yongmei Zhao et al, 2021, Pharmaceutics CrossRef